¼±Åà - È»ìǥŰ/¿£ÅÍŰ
´Ý±â - ESC
KMLE °Ë»ö
°Ë»ö ¼³Á¤
¿Â¶óÀÎ ÀÇÇмÀû
ÀÇÇпë¾î »çÀü
ÀÇÇоà¾î
ÀÇÇлçÀü
ÇÑ¿µ/¿µÇÑ»çÀü
¿µ¿µ»çÀü
»çÀÌÆ® ¼Ò°³
Àç°Ë»ö
"Complement C5 Convertase, Alternative Pathway"¿¡ ´ëÇÑ °æºÏ´ëÇб³ Ä¡°ú´ëÇÐ ±¸°³»°úÇб³½Ç »çÀü ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
¼³¸í
convertase
Àüȯ È¿¼Ò
alternative inheritance
±³´ë À¯Àü
alternative reaction
±³´ë ¹ÝÀÀ
complement activation
º¸Ã¼ Ȱ¼º ÀÛ¿ë, º¸Ã¼ Ȱ¼ºÈ
complement consumption test
º¸Ã¼ ¼Òºñ ½ÃÇè
complement fixation inhibition test
º¸Ã¼ °íÁ¤ ÀúÇØ ½ÃÇè
complement fixation test
º¸Ã¼ °áÇÕ ½ÃÇè, º¸Ã¼ °áÇÕ °Ë»ç, º¸Ã¼ °íÁ¤ °Ë»ç
complement fixing antibody
º¸Ã¼ °áÇÕ Ç×ü
complement splitting
º¸Ã¼ ºÐÇØ
complement-mediated cytotoxicity
º¸Ã¼ ¸Å°³¼º ¼¼Æ÷ µ¶¼º
inactivation of complement
º¸Ã¼ ºñµ¿È
serum complement titer
Ç÷û º¸Ã¼ °¡ÃøÁ¤
¸ðµç º¸Ã¼ Ȱ¼ºÀÇ ÃÑÇÕÀ¸·Î¼ ÃøÁ¤µÈ´Ù.
treponema pallidum complement fixation test
Æ®·¹Æ÷³×¸¶ º¸Ã¼ °áÇÕ ½ÃÇè
afferent neural pathway
±¸½É¼º ½Å°æ °æ·Î
¸»ÃÊ ºÎÀ§·ÎºÎÅÍ ÁßÃ߽Űæ°è·Î Àü´ÞµÇ´Â ½Å°æ ÀÓÆÞ½º.
anterolateral pathway
Àü¿ÜÃø·Î, Àü¿ÜÃø °æ·Î, Àü¿ÜÃø Åë·Î
Åë°¢, ¿Â°¢, ³Ã°¢ ¹× µÐÇÑ Ã˰¢ µî ¸¹Àº Á¾·ùÀÇ °¨°¢À» Àü´Þ.
´ÙÀ½
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
¼³¸í
ÅëÇÕ°Ë»ö ¿Ï·á
´ÙÀ½